Neo Ivy Capital Management’s Astera Labs ALAB Stock Holding History

Neo Ivy Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,764	Closed	-$105K	–	503
2025 Q1	$105K	Buy	+1,764	New	+$163K	0.03%	238

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

Neo Ivy Capital Management's ALAB Position: Q2 2025 in Review

Neo Ivy Capital Management sold out of Astera Labs (ALAB) in Q2 2025, closing a stake of 1,764 shares — an estimated $105K sold.

Neo Ivy Capital Management first reported a position in ALAB in Q1 2025 and held it in 1 quarter. The position peaked at $105K in Q1 2025. 513 funds tracked by Wall St. Rank hold ALAB as of Q2 2025.

Neo Ivy Capital Management reported no remaining Astera Labs position as of Q2 2025 after selling out during the quarter.
Neo Ivy Capital Management sold 1,764 Astera Labs shares in Q2 2025, an estimated $105K.
Neo Ivy Capital Management first reported a position in Astera Labs in Q1 2025 and held it in 1 quarter.
Neo Ivy Capital Management's Astera Labs position peaked at $105K in Q1 2025.
513 funds tracked by Wall St. Rank held Astera Labs as of Q2 2025.

Based on Neo Ivy Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.